Coumaphos; Revised Proposed Interim Registration Review Decision; Notice of Availability, 52341-52342 [2020-18598]
Download as PDF
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 165 / Tuesday, August 25, 2020 / Notices
Pennsylvania Ave. NW, Washington, DC
20460. EPA’s policy is that all
comments received will be included in
the public docket without change
including any personal information
provided, unless the comment includes
profanity, threats, information claimed
to be Confidential Business Information
(CBI), or other information whose
disclosure is restricted by statute.
Submit written comments and
recommendations to OMB for the
proposed information collection within
30 days of publication of this notice to
www.reginfo.gov/public/do/PRAMain.
Find this particular information
collection by selecting ‘‘Currently under
30-day Review—Open for Public
Comments’’ or by using the search
function.
FOR FURTHER INFORMATION CONTACT:
Robert Barles, Drinking Water
Protection Division, Office of Ground
Water and Drinking Water,
Environmental Protection Agency,
telephone number: 202–564–3814;
email address: barles.robert@epa.gov.
SUPPLEMENTARY INFORMATION:
Supporting documents, which explain
in detail the information that the EPA
will be collecting, are available in the
public docket for this ICR. The docket
can be viewed online at
www.regulations.gov or in person at the
EPA Docket Center, WJC West, Room
3334, 1301 Constitution Ave. NW,
Washington, DC. The telephone number
for the Docket Center is 202–566–1744.
For additional information about EPA’s
public docket, visit https://www.epa.gov/
dockets.
Abstract: The purpose of this
information collection is to identify the
infrastructure needs of public water
systems for the 20-year period from
January 2020 through December 2039.
EPA’s Office of Ground Water and
Drinking Water will collect these data to
comply with Sections 1452(h) and
1452(i)(4) of the Safe Drinking Water
Act (42 U.S.C. 300j–12). The Agency
will use a questionnaire to collect
capital investment need information
from selected community water systems
and not-for-profit non-community water
systems. Participation in the survey is
voluntary. The data from the
questionnaires will provide EPA with
new information from the field to assist
in the 2020 update to the Agency’s
assessment of the nationwide
infrastructure needs of public water
systems. Also, as mandated by section
1452(a)(1)(D)(ii) of the Safe Drinking
Water Act, EPA uses the results of the
latest survey to allocate Drinking Water
State Revolving Fund (DWSRF) monies
to the states. Under the allotment
VerDate Sep<11>2014
19:55 Aug 24, 2020
Jkt 250001
formula, each state receives a grant of
the annual DWSRF appropriation in
proportion to the state’s share of the
total national need, with the proviso
that each state receives at least one
percent of the total funds available.
Form numbers: 6100–03.
Respondents/affected entities:
Community water systems not-for-profit
non-community water systems, and
state agencies.
Respondent’s obligation to respond:
Voluntary.
Estimated number of respondents:
3,912 (total).
Frequency of response: One time.
Total estimated burden: 15,177 hours
(per year). Burden is defined at 5 CFR
1320.03(b).
Total estimated cost: $1,705,941 (per
year), includes $0 annualized capital or
operation and maintenance costs.
Changes in estimates: This is a new
ICR. The estimated total public
reporting burden over the entire fouryear length of the 2020 DWINSA is over
8,000 hours higher compared with the
ICR approved by OMB for the 2015
DWINSA survey (OMB control number
2040–0274). This burden increase is
almost entirely a result of the 2020
Survey being the first effort to collect
information on lead service line
inventories for all system types across
all states and territories as well as tribal
water systems.
Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2020–18568 Filed 8–24–20; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPP–2017–0751; FRL–10013–81]
Coumaphos; Revised Proposed
Interim Registration Review Decision;
Notice of Availability
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
This notice announces the
availability of and solicits public
comment on EPA’s revised proposed
interim registration review decision for
coumaphos.
DATES: Comments must be received on
or before October 26, 2020.
ADDRESSES: Submit your comments,
identified by the docket identification
(ID) number for the specific pesticide of
interest provided in the Table in Unit
IV., using the Federal eRulemaking
Portal at https://www.regulations.gov.
Follow the online instructions for
SUMMARY:
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
52341
submitting comments. Do not submit
electronically any information you
consider to be Confidential Business
Information (CBI) or other information
whose disclosure is restricted by statute.
Due to the public health concerns
related to COVID–19, the EPA Docket
Center (EPA/DC) and Reading Room is
closed to visitors with limited
exceptions. The staff continues to
provide remote customer service via
email, phone, and webform. For the
latest status information on EPA/DC
services and docket access, visit https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: For
pesticide specific information, contact:
The Chemical Review Manager for the
pesticide of interest identified in the
Table in Unit IV.
For general information on the
registration review program, contact:
Melanie Biscoe, Pesticide Re-Evaluation
Division (7508P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; telephone
number: (703) 305–7106; email address:
biscoe.melanie@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public
in general, and may be of interest to a
wide range of stakeholders including
environmental, human health, farm
worker, and agricultural advocates; the
chemical industry; pesticide users; and
members of the public interested in the
sale, distribution, or use of pesticides.
Since others also may be interested, the
Agency has not attempted to describe all
the specific entities that may be affected
by this action. If you have any questions
regarding the applicability of this action
to a particular entity, consult the
pesticide specific contact person listed
under FOR FURTHER INFORMATION
CONTACT: For pesticide specific
information, contact: The Chemical
Review Manager for the pesticide of
interest identified in the Table in Unit
IV.
For general information on the
registration review program, contact:
Melanie Biscoe, Pesticide Re-Evaluation
Division (7508P), Office of Pesticide
Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; telephone
number: (703) 305–7106; email address:
biscoe.melanie@epa.gov.
B. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit this
information to EPA through
E:\FR\FM\25AUN1.SGM
25AUN1
52342
Federal Register / Vol. 85, No. 165 / Tuesday, August 25, 2020 / Notices
regulations.gov or email. Clearly mark
the part or all of the information that
you claim to be CBI. For CBI
information on a disk or CD–ROM that
you mail to EPA, mark the outside of the
disk or CD–ROM as CBI and then
identify electronically within the disk or
CD–ROM the specific information that
is claimed as CBI. In addition to one
complete version of the comment that
includes information claimed as CBI, a
copy of the comment that does not
contain the information claimed as CBI
must be submitted for inclusion in the
public docket. Information so marked
will not be disclosed except in
accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments.
When preparing and submitting your
comments, see the commenting tips at
https://www.epa.gov/dockets/
comments.html.
II. Background
Registration review is EPA’s periodic
review of pesticide registrations to
ensure that each pesticide continues to
satisfy the statutory standard for
registration, that is, the pesticide can
perform its intended function without
unreasonable adverse effects on human
health or the environment. As part of
the registration review process, the
Agency has completed the revised
proposed interim decisions for
coumaphos listed in the Table in Unit
IV. Through this program, EPA is
ensuring that each pesticide’s
registration is based on current
scientific and other knowledge,
including its effects on human health
and the environment.
registrations of pesticides are to be
reviewed every 15 years. Under FIFRA,
a pesticide product may be registered or
remain registered only if it meets the
statutory standard for registration given
in FIFRA section 3(c)(5) (7 U.S.C.
136a(c)(5)). When used in accordance
with widespread and commonly
recognized practice, the pesticide
product must perform its intended
function without unreasonable adverse
effects on the environment; that is,
without any unreasonable risk to man or
the environment, or a human dietary
risk from residues that result from the
use of a pesticide in or on food.
III. Authority
IV. What action is the Agency taking?
EPA is conducting its registration
review of coumaphos pursuant to
section 3(g) of the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA)
and the Procedural Regulations for
Registration Review at 40 CFR part 155,
subpart C. Section 3(g) of FIFRA
provides, among other things, that the
Pursuant to 40 CFR 155.58, this notice
announces the availability of EPA’s
revised proposed interim registration
review decisions for coumaphos. The
revised proposed interim registration
review decision is supported by
rationale included in the docket
established for each chemical.
khammond on DSKJM1Z7X2PROD with NOTICES
TABLE—REGISTRATION REVIEW PROPOSED INTERIM DECISIONS BEING ISSUED
Chemical review manager and contact
information
Registration review case name and No.
Docket ID No.
Coumaphos (Case0018) ...................................
EPA–HQ–OPP–2008–0023 .............................
Michelle Nolan, nolan.michelle@epa.gov,
(703) 347–0258.
The registration review docket for a
pesticide includes earlier documents
related to the registration review case.
For example, the review opened with a
Preliminary Work Plan, for public
comment. A Final Work Plan was
placed in the docket following public
comment on the Preliminary Work Plan.
The documents in the dockets
describe EPA’s rationales for conducting
additional risk assessments for the
registration review of coumaphos, as
well as the Agency’s subsequent risk
findings and consideration of possible
risk mitigation measures. This revised
proposed interim registration review
decision is supported by the rationales
included in those documents. Following
public comment, the Agency will issue
an interim or final registration review
decision for coumaphos.
The registration review final rule at 40
CFR 155.58(a) provides for a minimum
60-day public comment period on all
proposed interim registration review
decisions. This comment period is
intended to provide an opportunity for
public input and a mechanism for
initiating any necessary amendments to
the proposed interim decision. All
comments should be submitted using
the methods in ADDRESSES and must be
received by EPA on or before the closing
date. These comments will become part
of the docket for coumaphos. Comments
received after the close of the comment
period will be marked ‘‘late.’’ EPA is not
required to consider these late
comments.
The proposed interim registration
review decision for coumaphos was
posted to the docket in May 2018 and
the public was invited to submit any
comments or new information during
the 60-day comment period. A comment
extension request was submitted by
Bayer Animal Health which resulted in
a 30-day extension or 90-day total
comment period. Comments from the
90-day comment period that were
received were considered and affected
the Agency’s revised proposed interim
decision. EPA addressed the comments
or information received during the 90day comment period for the proposed
interim decision and is issuing a revised
proposed interim decision for a 60-day
comment period. Pursuant to 40 CFR
155.58(c), the registration review case
docket for the chemicals listed in the
Table will remain open until all actions
required in the proposed interim
decision have been completed.
Background on the registration review
program is provided at: https://
www.epa.gov/pesticide-reevaluation.
VerDate Sep<11>2014
19:55 Aug 24, 2020
Jkt 250001
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Authority: 7 U.S.C. 136 et seq.
Dated: August 14, 2020.
Mary Reaves,
Acting Director, Pesticide Re-Evaluation
Division, Office of Pesticide Programs.
[FR Doc. 2020–18598 Filed 8–24–20; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[CERCLA–04–2020–2505; FRL–10012–64–
Region 4]
Pilot Mountain Superfund Site; Notice
of Settlement
Environmental Protection
Agency (EPA).
ACTION: Notice of proposed settlement.
AGENCY:
The United States
Environmental Protection Agency (EPA)
proposes to enter into a Settlement
Agreement for Recovery of Past
Response Costs with New River Tire
Recycling, LLC, concerning the Pilot
Mountain Superfund Site located in
Pilot Mountain, North Carolina. The
SUMMARY:
E:\FR\FM\25AUN1.SGM
25AUN1
Agencies
[Federal Register Volume 85, Number 165 (Tuesday, August 25, 2020)]
[Notices]
[Pages 52341-52342]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18598]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2017-0751; FRL-10013-81]
Coumaphos; Revised Proposed Interim Registration Review Decision;
Notice of Availability
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the availability of and solicits public
comment on EPA's revised proposed interim registration review decision
for coumaphos.
DATES: Comments must be received on or before October 26, 2020.
ADDRESSES: Submit your comments, identified by the docket
identification (ID) number for the specific pesticide of interest
provided in the Table in Unit IV., using the Federal eRulemaking Portal
at https://www.regulations.gov. Follow the online instructions for
submitting comments. Do not submit electronically any information you
consider to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute.
Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room is closed to visitors with
limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: For pesticide specific information,
contact: The Chemical Review Manager for the pesticide of interest
identified in the Table in Unit IV.
For general information on the registration review program,
contact: Melanie Biscoe, Pesticide Re-Evaluation Division (7508P),
Office of Pesticide Programs, Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number:
(703) 305-7106; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general, and may be of
interest to a wide range of stakeholders including environmental, human
health, farm worker, and agricultural advocates; the chemical industry;
pesticide users; and members of the public interested in the sale,
distribution, or use of pesticides. Since others also may be
interested, the Agency has not attempted to describe all the specific
entities that may be affected by this action. If you have any questions
regarding the applicability of this action to a particular entity,
consult the pesticide specific contact person listed under FOR FURTHER
INFORMATION CONTACT: For pesticide specific information, contact: The
Chemical Review Manager for the pesticide of interest identified in the
Table in Unit IV.
For general information on the registration review program,
contact: Melanie Biscoe, Pesticide Re-Evaluation Division (7508P),
Office of Pesticide Programs, Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone number:
(703) 305-7106; email address: [email protected].
B. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit this information to EPA through
[[Page 52342]]
regulations.gov or email. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information on a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at https://www.epa.gov/dockets/comments.html.
II. Background
Registration review is EPA's periodic review of pesticide
registrations to ensure that each pesticide continues to satisfy the
statutory standard for registration, that is, the pesticide can perform
its intended function without unreasonable adverse effects on human
health or the environment. As part of the registration review process,
the Agency has completed the revised proposed interim decisions for
coumaphos listed in the Table in Unit IV. Through this program, EPA is
ensuring that each pesticide's registration is based on current
scientific and other knowledge, including its effects on human health
and the environment.
III. Authority
EPA is conducting its registration review of coumaphos pursuant to
section 3(g) of the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA) and the Procedural Regulations for Registration Review at 40
CFR part 155, subpart C. Section 3(g) of FIFRA provides, among other
things, that the registrations of pesticides are to be reviewed every
15 years. Under FIFRA, a pesticide product may be registered or remain
registered only if it meets the statutory standard for registration
given in FIFRA section 3(c)(5) (7 U.S.C. 136a(c)(5)). When used in
accordance with widespread and commonly recognized practice, the
pesticide product must perform its intended function without
unreasonable adverse effects on the environment; that is, without any
unreasonable risk to man or the environment, or a human dietary risk
from residues that result from the use of a pesticide in or on food.
IV. What action is the Agency taking?
Pursuant to 40 CFR 155.58, this notice announces the availability
of EPA's revised proposed interim registration review decisions for
coumaphos. The revised proposed interim registration review decision is
supported by rationale included in the docket established for each
chemical.
Table--Registration Review Proposed Interim Decisions Being Issued
------------------------------------------------------------------------
Chemical review
Registration review case name manager and
and No. Docket ID No. contact
information
------------------------------------------------------------------------
Coumaphos (Case0018)............ EPA-HQ-OPP-2008-00 Michelle Nolan,
23. [email protected], (703) 347-
0258.
------------------------------------------------------------------------
The registration review docket for a pesticide includes earlier
documents related to the registration review case. For example, the
review opened with a Preliminary Work Plan, for public comment. A Final
Work Plan was placed in the docket following public comment on the
Preliminary Work Plan.
The documents in the dockets describe EPA's rationales for
conducting additional risk assessments for the registration review of
coumaphos, as well as the Agency's subsequent risk findings and
consideration of possible risk mitigation measures. This revised
proposed interim registration review decision is supported by the
rationales included in those documents. Following public comment, the
Agency will issue an interim or final registration review decision for
coumaphos.
The registration review final rule at 40 CFR 155.58(a) provides for
a minimum 60-day public comment period on all proposed interim
registration review decisions. This comment period is intended to
provide an opportunity for public input and a mechanism for initiating
any necessary amendments to the proposed interim decision. All comments
should be submitted using the methods in ADDRESSES and must be received
by EPA on or before the closing date. These comments will become part
of the docket for coumaphos. Comments received after the close of the
comment period will be marked ``late.'' EPA is not required to consider
these late comments.
The proposed interim registration review decision for coumaphos was
posted to the docket in May 2018 and the public was invited to submit
any comments or new information during the 60-day comment period. A
comment extension request was submitted by Bayer Animal Health which
resulted in a 30-day extension or 90-day total comment period. Comments
from the 90-day comment period that were received were considered and
affected the Agency's revised proposed interim decision. EPA addressed
the comments or information received during the 90-day comment period
for the proposed interim decision and is issuing a revised proposed
interim decision for a 60-day comment period. Pursuant to 40 CFR
155.58(c), the registration review case docket for the chemicals listed
in the Table will remain open until all actions required in the
proposed interim decision have been completed.
Background on the registration review program is provided at:
https://www.epa.gov/pesticide-reevaluation.
Authority: 7 U.S.C. 136 et seq.
Dated: August 14, 2020.
Mary Reaves,
Acting Director, Pesticide Re-Evaluation Division, Office of Pesticide
Programs.
[FR Doc. 2020-18598 Filed 8-24-20; 8:45 am]
BILLING CODE 6560-50-P